Posts Tagged ‘FFDM’

End of an Era

Posted on: December 29th, 2023 by admin 10 Comments

In mid-2011, following the advice of Philip van Zyl of Get Social Media, I started writing a regular weekly blog to draw […]

Now There’s a Great Idea!

Posted on: November 24th, 2023 by admin 3 Comments

During the past week, one of the regular readers of these blogs brought to my attention a company called Litmaps. Dubbed […]

The Minnies and Breast Imaging

Posted on: November 3rd, 2023 by admin 2 Comments

It was 24 years ago that a new website called AuntMinnie.com was launched, providing interesting news on medical imaging. Apparently, the provenance for Aunt […]

Finally – A Well-Executed Study on AI

Posted on: August 11th, 2023 by admin

There are currently more than 20 artificial intelligence (AI) applications for breast imaging approved by the Food and Drug Administration (FDA) in […]

Focus on Breast Screening in Europe

Posted on: June 16th, 2023 by admin

Two weeks ago, the European Society of Radiology hosted an online webinar entitled “Breast cancer screening: the updated EU Council recommendations and […]

A Flurry of Screening Advice

Posted on: May 12th, 2023 by admin 1 Comment

Advocates on all sides of the breast screening debate are agreed that the earlier a malignant tumour is detected, the […]

Is DBT There Yet?

Posted on: March 17th, 2023 by admin 1 Comment

Twelve years ago, the FDA approved Hologic’s digital breast tomosynthesis (DBT) system – sometimes incorrectly referred to as 3D mammography – as […]

Mother and Son … and AI

Posted on: March 10th, 2023 by admin 1 Comment

When he was growing up in Budapest, Hungary, Peter Kecskemethy would spend time at one of the city’s largest hospitals […]

A Peek into the Future

Posted on: December 2nd, 2022 by admin 1 Comment

Eleven years ago, we reviewed the Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer, by oncologist Dr Siddhartha Mukherjee (© […]

DBT and AI – What a Combination!

Posted on: November 11th, 2022 by admin

Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]